Event-Driven Stocks

SYNLOGIC, INC.

SYBXOTC

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$0$8,000$3.4M$1.2M$1.8M$545,000
Operating income−$4.0M−$41.0M−$55.2M−$67.4M−$60.8M−$60.5M
Net income−$1.0M−$23.4M−$61.3M−$66.1M−$60.6M−$59.2M
Total assets$15.4M$19.8M$75.5M$110.9M$174.7M$143.8M
Total liabilities——————
Equity$11.9M$12.8M$32.8M$82.6M$147.3M$115.1M
EPS (diluted)$-0.08$-1.92$-9.42$-13.83$-1.09—
Shares out.11.7M11.6M67.7M70.2M39.7M32.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
—
Net margin
—
Return on equity
−8.5%
Return on assets
−6.5%
Return on capital (ROCE)
−33.8%
Liabilities / assets
—
Debt / equity
—
Book value / share
$1.01
Revenue growth (YoY)
−100.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
21.7%high accruals
Piotroski F-Score
2/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
33
/ 100
Profitability 0Growth 0Catalyst 67Earnings quality 0Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 warning● 0 good
  • Revenue declined year-over-year
  • Negative operating cash flow
  • High accruals — earnings-quality risk

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20263,0591.0-4.3%
Apr 30, 20263,1981.0-4.1%
Apr 15, 20263,3341.0-72.4%
Mar 31, 202612,0751.0-0.5%
Mar 13, 202612,1321.00.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)